These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8693548)

  • 1. Comparison of conventional oral cyclosporine and cyclosporine microemulsion formulations in children with a liver transplant.
    Hoppu K; Jalanko H; Laine J; Holmberg C
    Transplantation; 1996 Jul; 62(1):66-71. PubMed ID: 8693548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the conventional and microemulsion formulations of cyclosporine in pancreas-kidney transplant recipients with gastroparesis.
    van der Pijl JW; Srivastava N; Denouël J; Burggraaf J; Schoemaker RC; van der Woude FJ; Cohen AF
    Transplantation; 1996 Aug; 62(4):456-62. PubMed ID: 8781610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion and pharmacokinetic studies of a microemulsion formulation of cyclosporine in pediatric liver transplant patients.
    D'Agostino D; Gimenez M; Yamaguchi B; Glancszpigel R; Vinuesa F; Gamba M; Ciardullo M; de Santibaes E
    Transplantation; 1996 Oct; 62(8):1068-71. PubMed ID: 8900303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
    Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney function after 1:1 conversion to the cyclosporine microemulsion formulation in children with liver allografts.
    Laine J; Hoppu K; Jalanko H; Rönnholm K; Holmberg C
    Transplantation; 1997 Jun; 63(12):1768-72. PubMed ID: 9210502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients.
    Dunn S; Cooney G; Sommerauer J; Lindsay C; McDiarmid S; Wong RL; Chang CT; Smith HT; Choc MG
    Transplantation; 1997 Jun; 63(12):1762-7. PubMed ID: 9210501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.
    Kovarik JM; Mueller EA; Richard F; Niese D; Halloran PF; Jeffery J; Paul LC; Keown PA
    Transplantation; 1996 Sep; 62(6):759-63. PubMed ID: 8824473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients.
    Dunn SP; Cooney GF; Kulinsky A; Falkenstein K; Pierson A; Elder CA; Meligeni J
    Transplantation; 1995 Dec; 60(12):1438-42. PubMed ID: 8545871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cyclosporine in pediatric long-term liver transplant recipients converted from Sandimmun to Neoral.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Brodehl J
    Transpl Int; 1997; 10(6):419-25. PubMed ID: 9428114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year.
    Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Budde K; Waiser J; Luft FC
    Nephrol Dial Transplant; 1996 Jan; 11(1):165-72. PubMed ID: 8649628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.
    Tokui K; Kimata T; Uchida K; Yuasa H; Hayashi Y; Itatsu T; Nabeshima T
    Ther Drug Monit; 2004 Jun; 26(3):287-94. PubMed ID: 15167630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile-independent absorption of cyclosporine from a microemulsion formulation in liver transplant patients.
    Mueller EA; Kallay Z; Kovarik JM; Richard F; Wiesinger O; Schmidt K; Scheele J
    Transplantation; 1995 Sep; 60(5):515-7. PubMed ID: 7676504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group.
    Keown P; Landsberg D; Halloran P; Shoker A; Rush D; Jeffery J; Russell D; Stiller C; Muirhead N; Cole E; Paul L; Zaltzman J; Loertscher R; Daloze P; Dandavino R; Boucher A; Handa P; Lawen J; Belitsky P; Parfrey P
    Transplantation; 1996 Dec; 62(12):1744-52. PubMed ID: 8990355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.
    Neumayer HH; Budde K; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Clin Nephrol; 1996 May; 45(5):326-31. PubMed ID: 8738665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microemulsion of cyclosporine without intravenous cyclosporine in liver transplantation.
    Hemming AW; Greig PD; Cattral MS; Chung SW; Lilly LB; Aljumah AA; Levy GA
    Transplantation; 1996 Dec; 62(12):1798-802. PubMed ID: 8990366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
    Noble S; Markham A
    Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
    Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.